Full Name
Dr Laurent Mallet
Hospital/Organisation/Company
European Directorate for the Quality of Medicines & HealthCare (EDQM)
Speaker Bio
Laurent Mallet is the Head of the Biological Standardisation, OMCL Networkand HealthCare Department at the European Directorate for the Quality of Medicines and HealthCare (EDQM) since 1 December 2019.
Laurent Mallet obtained his Master of Science in Biochemistry from Claude Bernard University, Lyon (France) and completed his PhD work in Virology and Molecular Biology under the co-direction of Professor Michèle Aymard (National Reference Center for Enterovirus, Lyon) and Dr François Pelloquin (Sanofi Pasteur, formerly Pasteur Mérieux-Connaught).
He obtained his PhD in 1996. After several positions within Sanofi Pasteur in France and in Canada, he was appointed Global Head of Analytical Sciences at Sanofi Pasteur, where he remained until November 2019. He joined the EDQM in December 2019. He was a member of several expert committees,including EDQM/European Pharmacopoeia Group of Experts 15 (Human vaccines and sera), and a stakeholder in the French Pharmacopoeia Committee for “Biological Products and Innovative Therapies”. He was also involved in several WHO working groups on vaccines, including the WHO Study Group on Cell Substrates.
He currently represents the EDQM on the WHO Expert Committee on Biological Standardisation (ECBS), and in the NC3Rs Steering Committee reviewing animal testing requirements in WHO biologicals guidelines, the COVAX Regulatory Advisory Group and the implementation working group for the ICH Q5A revision. He is also a member of the IABS Board
Laurent Mallet obtained his Master of Science in Biochemistry from Claude Bernard University, Lyon (France) and completed his PhD work in Virology and Molecular Biology under the co-direction of Professor Michèle Aymard (National Reference Center for Enterovirus, Lyon) and Dr François Pelloquin (Sanofi Pasteur, formerly Pasteur Mérieux-Connaught).
He obtained his PhD in 1996. After several positions within Sanofi Pasteur in France and in Canada, he was appointed Global Head of Analytical Sciences at Sanofi Pasteur, where he remained until November 2019. He joined the EDQM in December 2019. He was a member of several expert committees,including EDQM/European Pharmacopoeia Group of Experts 15 (Human vaccines and sera), and a stakeholder in the French Pharmacopoeia Committee for “Biological Products and Innovative Therapies”. He was also involved in several WHO working groups on vaccines, including the WHO Study Group on Cell Substrates.
He currently represents the EDQM on the WHO Expert Committee on Biological Standardisation (ECBS), and in the NC3Rs Steering Committee reviewing animal testing requirements in WHO biologicals guidelines, the COVAX Regulatory Advisory Group and the implementation working group for the ICH Q5A revision. He is also a member of the IABS Board
